We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Allergy Therapeutics Plc | LSE:AGY | London | Ordinary Share | GB00B02LCQ05 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.875 | 2.75 | 3.00 | 2.875 | 2.875 | 2.88 | 973,172 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 59.59M | -43.07M | -0.0090 | -3.19 | 136.8M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/6/2023 19:28 | ZenI suggest you should read coins post again.Hi | jimmyloser | |
23/6/2023 19:09 | They maybe Chinese private equity firm, but doesn't give them right to just ignore European FDI regulatory approvals. That is just not true. | zen12 | |
23/6/2023 14:55 | coinbase, I have voted that excellent post UP. There is no denying anything that you have written. If only for the hell of it, I will ride this one out. jl | jimmyloser | |
23/6/2023 14:11 | Jimmyloser, I wish I shared your optimism. I’ve been doing this for far too long and been burnt more times than I care to remember. I sold the last of my shares yesterday at a 93.67% loss and would urge you and others to look again before averaging down. Towards the beginning of last year there were very few reasons not to invest in Allergy Therapeutics, the science was sound, the company was in good financial health and the principle shareholders (Abbott being the largest) were top-notch. Since then it’s been a completely different story. In May of last year Nick Wykeman, the then CFO, stepped down for no reason and to date still hasn’t been permanently replaced. Four months later the company voluntarily paused production at the Freeman facility, crippling cashflow and falling foul of the terms of its agreement with NatWest. To plug the gap Southern Fox and ZQ Capital loaned the company 10 million with conditions to take it private in the event of the most minor of infringements. Then on the 28th December 2022 Scott Leinenweber, Abbott Vice President, Investor Relations, Licensing and Acquisitions, resigned as a Non-Executive Director. I can’t imagine that Scott is the sort of chap that would suffer fools gladly, nor would he have jumped ship if either he or Abbott believed in the company's ability to deliver value to shareholders. The bottom line is that Abbott, the worlds largest healthcare company, and River and Mercantile Asset Management, with 4.1 billion under management and a keen eye for biotechnology businesses, are largely out and an obscure Chinese private equity firm are in, subject to certain European FDI regulatory approvals none of which are nailed on. In conclusion I think that there is a very good chance that what was a brilliant little company will go bust or be taken private before the end of next month. | coinbase | |
23/6/2023 12:04 | So, we now have a new financial category of investors emerging - 'certified investors'. Before long, their investment performance will be compared agaist benchmarks. | farmergeorge | |
23/6/2023 11:54 | Ok, I need to be certified but I've just had a nibble | jpuff | |
23/6/2023 10:22 | Perhaps you are right, hope is the only thing left here. | farmergeorge | |
23/6/2023 10:14 | FG Where have you been? It is the only one left to me lol. | jimmyloser | |
23/6/2023 10:00 | jimmyloser, whilst I agree with you, keeping fingers crossed is not an investment strategy. | farmergeorge | |
23/6/2023 09:37 | Becca, lol, we have seen better days, for now we will just have to wear out the worry beads and keep our fingers crossed. Good luck. | jimmyloser | |
23/6/2023 09:23 | We will see Jimmy dear. The funniest part starts right now. | beccasan | |
23/6/2023 08:52 | Whilst I too believe that there is more to this than meets our eye. I do however believe that the management do know what they are doing, they have an admirable record of delivering compound growth, whilst also delivering innovation. They are guided by a blue chip NOMAD and I believe that these are the darkest days. There is a huge market for their products once through the gate, and we are closer to opening that gate now, than we have ever been. It has been a bad year for sure, but it will soon be behind us. USA, China and UK et al, all need what we are developing. As someone said, park our emotion and see if we are still here and more relevantly, where we are share price wise come the autumn. Companies have all sorts of reasons for selling as they do for buying. impo | jimmyloser | |
23/6/2023 08:17 | Clearly there is something we don't know that goes far beyond simple insane economic and financial management. I don't see any conspiracy or speculation. But that's not good news. I only see Chaos from a mediocre management that crosses over from top management to the top and the management of the various departments and affiliates. Chaos that is now cathartically expressing itself all together. This company therefore has no hope. The probability that at least one trial will be successful is close to absolute zero. Because the history of this company proves it. But even the slightest hope that it will succeed is not even remotely enough to reverse fate. A clinical study means nothing. It does not imply registration in a country, it does not imply commercial success of the product. Here is just a widespread and widely mismanaged company, products canceled by the regulatory authorities of the most important countries and something else that we mysteriously still don't know that intuitively is happening very seriously in one or more affiliates. River and Mercantile must have sold for very serious reasons. Something very serious. That should be better investigated and that sooner or later it will come out. The majority shareholders I don't think will want to invest again and I don't think anyone else will. I'll leave it to you to simply deduce what will happen if my assessment is correct. | beccasan | |
22/6/2023 15:56 | It's game over here by looks of it | jpuff | |
22/6/2023 15:51 | 23mill dumped at 0.80p - | tomboyb | |
22/6/2023 15:23 | Terminal 1 | volsung | |
22/6/2023 15:09 | Terminal?! | coinbase | |
22/6/2023 14:40 | How they going to raise money though? It will probably end up being taken over by the majority shareholder and sadly you will be wiped out. | amishp67 | |
22/6/2023 13:01 | So you're currently getting counselling lol....never understood why some PIs waste time on these boards. Don't like, then move on plenty of other stocks requiring your great insight...that should add don't require counselling! | zen12 | |
22/6/2023 12:48 | Book me in :-) | jimmyloser | |
22/6/2023 12:37 | Anyone who buys stocks like this needs counselling | volsung | |
22/6/2023 11:17 | If the grass trials are as clearly expected a huge success and progress is being made on nuts, raising more money will be no problem. Consolidation beckons. I am trying to believe that there is a master plan at play. | jimmyloser | |
22/6/2023 11:00 | Its the 2nd part that is the killer - More monies will be required later this year - | tomboyb | |
22/6/2023 10:35 | Selling at any price it seems - | tomboyb | |
22/6/2023 10:23 | River and Mercantile, the only non 'Insider' large scale investor, appears to be liquidating its stake, getting about 1.125p. This tells us that it has no confidence in the idea of waiting for the Open Offer at 1p and then taking its chances with a closely-held company with the current management still in charge. This is troubling as a) R&M is a professional investor and so better qualified to make this decision and b) it almost certainly has access to management and therefore better information than us. The path ahead is treacherous. 1) the Open Offer might never happen (unless I missed it, the Insiders have yet to get FDI clearance; the board has failed to answer the question of who is managing this process and controlling the risks. If there is no clearance AGY is handed to the Insiders free, owing to the shameful terms of the loan agreement). 2) if the Open Offer does happen, the company will be closely held and "might" be run in the interests of the Insiders, especially as there is yet more funding required this year. This is another issue the board has declined to comment on. That R&M made the decision to take a huge loss rather than 'follow its money' on the treacherous path is deeply concerning. Any views? | 1kckeith |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions